BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lara MC, Weiss B, Illa I, Madoz P, Massuet L, Andreu AL, Valentino ML, Anikster Y, Hirano M, Marti R. Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology 2006;67:1461-3. [DOI: 10.1212/01.wnl.0000239824.95411.52] [Cited by in Crossref: 74] [Cited by in F6Publishing: 66] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Filosto M, Scarpelli M, Tonin P, Lucchini G, Pavan F, Santus F, Parini R, Donati MA, Cotelli MS, Vielmi V, Todeschini A, Canonico F, Tomelleri G, Padovani A, Rovelli A. Course and management of allogeneic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy. J Neurol 2012;259:2699-706. [PMID: 22711161 DOI: 10.1007/s00415-012-6572-9] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
2 Pacitti D, Levene M, Garone C, Nirmalananthan N, Bax BE. Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far. Front Genet 2018;9:669. [PMID: 30627136 DOI: 10.3389/fgene.2018.00669] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
3 Hirano M, Garone C, Quinzii CM. CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders. Biochim Biophys Acta 2012;1820:625-31. [PMID: 22274133 DOI: 10.1016/j.bbagen.2012.01.006] [Cited by in Crossref: 66] [Cited by in F6Publishing: 54] [Article Influence: 6.6] [Reference Citation Analysis]
4 Bax BE. Mitochondrial neurogastrointestinal encephalomyopathy: approaches to diagnosis and treatment. J Transl Genet Genom 2020;4:1-16. [PMID: 32914088 DOI: 10.20517/jtgg.2020.08] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
5 Nightingale H, Pfeffer G, Bargiela D, Horvath R, Chinnery PF. Emerging therapies for mitochondrial disorders. Brain 2016;139:1633-48. [PMID: 27190030 DOI: 10.1093/brain/aww081] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
6 Suomalainen A, Isohanni P. Mitochondrial DNA depletion syndromes--many genes, common mechanisms. Neuromuscul Disord 2010;20:429-37. [PMID: 20444604 DOI: 10.1016/j.nmd.2010.03.017] [Cited by in Crossref: 144] [Cited by in F6Publishing: 127] [Article Influence: 12.0] [Reference Citation Analysis]
7 De Vocht C, Ranquin A, Willaert R, Van Ginderachter JA, Vanhaecke T, Rogiers V, Versées W, Van Gelder P, Steyaert J. Assessment of stability, toxicity and immunogenicity of new polymeric nanoreactors for use in enzyme replacement therapy of MNGIE. J Control Release 2009;137:246-54. [PMID: 19371766 DOI: 10.1016/j.jconrel.2009.03.020] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
8 Ariaudo C, Daidola G, Ferrero B, Guarena C, Burdese M, Segoloni GP, Biancone L. Mitochondrial neurogastrointestinal encephalomyopathy treated with peritoneal dialysis and bone marrow transplantation. J Nephrol 2015;28:125-7. [PMID: 24599829 DOI: 10.1007/s40620-014-0069-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
9 Gopan A, Sarma MS. Mitochondrial hepatopathy: Respiratory chain disorders- ‘breathing in and out of the liver’. World J Hepatol 2021; 13(11): 1707-1726 [PMID: 34904040 DOI: 10.4254/wjh.v13.i11.1707] [Reference Citation Analysis]
10 Antonucci A, Fronzoni L, Cogliandro L, Cogliandro RF, Caputo C, Giorgio RD, Pallotti F, Barbara G, Corinaldesi R, Stanghellini V. Chronic intestinal pseudo-obstruction. World J Gastroenterol 2008; 14(19): 2953-2961 [PMID: 18494042 DOI: 10.3748/wjg.14.2953] [Cited by in CrossRef: 129] [Cited by in F6Publishing: 91] [Article Influence: 9.2] [Reference Citation Analysis]
11 Di Meo I, Lamperti C, Tiranti V. Mitochondrial diseases caused by toxic compound accumulation: from etiopathology to therapeutic approaches. EMBO Mol Med. 2015;7:1257-1266. [PMID: 26194912 DOI: 10.15252/emmm.201505040] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
12 Yadak R, Cabrera-Pérez R, Torres-Torronteras J, Bugiani M, Haeck JC, Huston MW, Bogaerts E, Goffart S, Jacobs EH, Stok M, Leonardelli L, Biasco L, Verdijk RM, Bernsen MR, Ruijter G, Martí R, Wagemaker G, van Til NP, de Coo IFM. Preclinical Efficacy and Safety Evaluation of Hematopoietic Stem Cell Gene Therapy in a Mouse Model of MNGIE. Mol Ther Methods Clin Dev 2018;8:152-65. [PMID: 29687034 DOI: 10.1016/j.omtm.2018.01.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
13 Filosto M, Cotti Piccinelli S, Caria F, Gallo Cassarino S, Baldelli E, Galvagni A, Volonghi I, Scarpelli M, Padovani A. Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE-MTDPS1). J Clin Med 2018;7:E389. [PMID: 30373120 DOI: 10.3390/jcm7110389] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
14 Parés M, Fornaguera C, Vila-Julià F, Oh S, Fan SHY, Tam YK, Comes N, Vidal F, Martí R, Borrós S, Barquinero J. Preclinical Assessment of a Gene-Editing Approach in a Mouse Model of Mitochondrial Neurogastrointestinal Encephalomyopathy. Hum Gene Ther 2021;32:1210-23. [PMID: 34498979 DOI: 10.1089/hum.2021.152] [Reference Citation Analysis]
15 Copeland WC. Defects in mitochondrial DNA replication and human disease. Crit Rev Biochem Mol Biol 2012;47:64-74. [PMID: 22176657 DOI: 10.3109/10409238.2011.632763] [Cited by in Crossref: 115] [Cited by in F6Publishing: 104] [Article Influence: 11.5] [Reference Citation Analysis]
16 Spinazzola A, Zeviani M. Disorders from perturbations of nuclear-mitochondrial intergenomic cross-talk. J Intern Med 2009;265:174-92. [PMID: 19192035 DOI: 10.1111/j.1365-2796.2008.02059.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
17 Falcão de Campos C, Oliveira Santos M, Roque R, Conceição I, de Carvalho M. Mitochondrial Neurogastrointestinal Encephalomyopathy: Novel Pathogenic Mutation in Thymidine Phosphorylase Gene in a Patient from Cape Verde Islands. Case Rep Neurol Med 2019;2019:5976410. [PMID: 31885962 DOI: 10.1155/2019/5976410] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
18 Finsterer J. Inherited Mitochondrial Disorders. In: Scatena R, Bottoni P, Giardina B, editors. Advances in Mitochondrial Medicine. Dordrecht: Springer Netherlands; 2012. pp. 187-213. [DOI: 10.1007/978-94-007-2869-1_8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
19 Saito K, Kimura N, Oda N, Shimomura H, Kumada T, Miyajima T, Murayama K, Tanaka M, Fujii T. Pyruvate therapy for mitochondrial DNA depletion syndrome. Biochim Biophys Acta 2012;1820:632-6. [PMID: 21855607 DOI: 10.1016/j.bbagen.2011.08.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
20 Rötig A, Poulton J. Genetic causes of mitochondrial DNA depletion in humans. Biochim Biophys Acta 2009;1792:1103-8. [PMID: 19596444 DOI: 10.1016/j.bbadis.2009.06.009] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 4.7] [Reference Citation Analysis]
21 Levene M, Bain MD, Moran NF, Nirmalananthan N, Poulton J, Scarpelli M, Filosto M, Mandel H, MacKinnon AD, Fairbanks L, Pacitti D, Bax BE. Safety and Efficacy of Erythrocyte Encapsulated Thymidine Phosphorylase in Mitochondrial Neurogastrointestinal Encephalomyopathy. J Clin Med 2019;8:E457. [PMID: 30959750 DOI: 10.3390/jcm8040457] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
22 Ramón J, Vila-Julià F, Molina-Granada D, Molina-Berenguer M, Melià MJ, García-Arumí E, Torres-Torronteras J, Cámara Y, Martí R. Therapy Prospects for Mitochondrial DNA Maintenance Disorders. Int J Mol Sci 2021;22:6447. [PMID: 34208592 DOI: 10.3390/ijms22126447] [Reference Citation Analysis]
23 Zaidman I, Elhasid R, Gefen A, Yahav Dovrat A, Mutaz S, Shaoul R, Eshach Adiv O, Mandel H, Tal G. Hematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalopathy: A single-center experience underscoring the multiple factors involved in the prognosis. Pediatr Blood Cancer 2021;68:e28926. [PMID: 33533561 DOI: 10.1002/pbc.28926] [Reference Citation Analysis]
24 Torres-Torronteras J, Gómez A, Eixarch H, Palenzuela L, Pizzorno G, Hirano M, Andreu AL, Barquinero J, Martí R. Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE. Gene Ther 2011;18:795-806. [PMID: 21451581 DOI: 10.1038/gt.2011.24] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
25 Copeland WC. Inherited mitochondrial diseases of DNA replication. Annu Rev Med 2008;59:131-46. [PMID: 17892433 DOI: 10.1146/annurev.med.59.053006.104646] [Cited by in Crossref: 200] [Cited by in F6Publishing: 185] [Article Influence: 14.3] [Reference Citation Analysis]
26 Cogliandro RF, De Giorgio R, Barbara G, Cogliandro L, Concordia A, Corinaldesi R, Stanghellini V. Chronic intestinal pseudo-obstruction. Best Practice & Research Clinical Gastroenterology 2007;21:657-69. [DOI: 10.1016/j.bpg.2007.03.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
27 Torres-Torronteras J, Cabrera-Pérez R, Barba I, Costa C, de Luna N, Andreu AL, Barquinero J, Hirano M, Cámara Y, Martí R. Long-Term Restoration of Thymidine Phosphorylase Function and Nucleoside Homeostasis Using Hematopoietic Gene Therapy in a Murine Model of Mitochondrial Neurogastrointestinal Encephalomyopathy. Hum Gene Ther 2016;27:656-67. [PMID: 27004974 DOI: 10.1089/hum.2015.160] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
28 Boschetti E, D'Alessandro R, Bianco F, Carelli V, Cenacchi G, Pinna AD, Del Gaudio M, Rinaldi R, Stanghellini V, Pironi L, Rhoden K, Tugnoli V, Casali C, De Giorgio R. Liver as a source for thymidine phosphorylase replacement in mitochondrial neurogastrointestinal encephalomyopathy. PLoS One 2014;9:e96692. [PMID: 24802030 DOI: 10.1371/journal.pone.0096692] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
29 Finsterer J. Treatment of central nervous system manifestations in mitochondrial disorders: Treatment of mitochondrial disorders. European Journal of Neurology 2011;18:28-38. [DOI: 10.1111/j.1468-1331.2010.03086.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
30 Schiff M, Bénit P, Jacobs HT, Vockley J, Rustin P. Therapies in inborn errors of oxidative metabolism. Trends Endocrinol Metab 2012;23:488-95. [PMID: 22633959 DOI: 10.1016/j.tem.2012.04.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
31 Halter JP, Michael W, Schüpbach M, Mandel H, Casali C, Orchard K, Collin M, Valcarcel D, Rovelli A, Filosto M, Dotti MT, Marotta G, Pintos G, Barba P, Accarino A, Ferra C, Illa I, Beguin Y, Bakker JA, Boelens JJ, de Coo IF, Fay K, Sue CM, Nachbaur D, Zoller H, Sobreira C, Pinto Simoes B, Hammans SR, Savage D, Martí R, Chinnery PF, Elhasid R, Gratwohl A, Hirano M. Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy. Brain 2015;138:2847-58. [PMID: 26264513 DOI: 10.1093/brain/awv226] [Cited by in Crossref: 88] [Cited by in F6Publishing: 72] [Article Influence: 12.6] [Reference Citation Analysis]
32 Baker MK, Schutte CM, Ranchhod N, Brittain D, van Rensburg JE. Transient clinical improvement of a mitochondrial neurogastrointestinal encephalomyopathy-like syndrome after allogeneic haematopoietic stem cell transplantation. BMJ Case Rep 2017;2017:bcr-2016-218276. [PMID: 28765176 DOI: 10.1136/bcr-2016-218276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
33 Lara MC, Valentino ML, Torres-torronteras J, Hirano M, Martí R. Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE): Biochemical Features and Therapeutic Approaches. Bioscience Reports 2007;27:151-63. [DOI: 10.1007/s10540-007-9043-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
34 Garone C, Tadesse S, Hirano M. Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy. Brain. 2011;134:3326-3332. [PMID: 21933806 DOI: 10.1093/brain/awr245] [Cited by in Crossref: 127] [Cited by in F6Publishing: 111] [Article Influence: 11.5] [Reference Citation Analysis]
35 Spinazzola A, Zeviani M. Mitochondrial diseases: a cross-talk between mitochondrial and nuclear genomes. Adv Exp Med Biol 2009;652:69-84. [PMID: 20225020 DOI: 10.1007/978-90-481-2813-6_6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
36 Balasubramaniam S, Duley JA, Christodoulou J. Inborn errors of pyrimidine metabolism: clinical update and therapy. J Inherit Metab Dis 2014;37:687-98. [PMID: 25030255 DOI: 10.1007/s10545-014-9742-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
37 Poulton J, Holt IJ. 163rd ENMC International Workshop: nucleoid and nucleotide biology in syndromes of mitochondrial DNA depletion myopathy 12-14 December 2008, Naarden, The Netherlands. Neuromuscul Disord 2009;19:439-43. [PMID: 19464176 DOI: 10.1016/j.nmd.2009.04.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
38 Finsterer J. Clinical Therapeutic Management of Human Mitochondrial Disorders. Pediatric Neurology 2020;113:66-74. [DOI: 10.1016/j.pediatrneurol.2020.07.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Karyampudi A, Srivastava P, Mandal K, Yadav P, Ghoshal UC, Verma A, Phadke SR. Novel sequence variations in the thymidine phosphorylase gene causing mitochondrial neurogastrointestinal encephalopathy. Clin Dysmorphol 2016;25:156-62. [PMID: 27261974 DOI: 10.1097/MCD.0000000000000137] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
40 Chinnery PF. Mutations in SUCLA2: a tandem ride back to the Krebs cycle. Brain 2007;130:606-9. [DOI: 10.1093/brain/awm023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
41 Granero Castro P, Fernández Arias S, Moreno Gijón M, Alvarez Martínez P, Granero Trancón J, Álvarez Pérez JA, Lamamie Clairac E, González González JJ. Emergency surgery in chronic intestinal pseudo-obstruction due to mitochondrial neurogastrointestinal encephalomyopathy: case reports. Int Arch Med. 2010;3:35. [PMID: 21143863 DOI: 10.1186/1755-7682-3-35] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
42 McInnes J. Mitochondrial-associated metabolic disorders: foundations, pathologies and recent progress. Nutr Metab (Lond) 2013;10:63. [PMID: 24499129 DOI: 10.1186/1743-7075-10-63] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
43 Orsucci D, Ienco EC, Siciliano G, Mancuso M. Mitochondrial disorders and drugs: what every physician should know. Drugs Context 2019;8:212588. [PMID: 31391854 DOI: 10.7573/dic.212588] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
44 Finsterer J. Treatment of mitochondrial disorders. Eur J Paediatr Neurol 2010;14:29-44. [PMID: 19692274 DOI: 10.1016/j.ejpn.2009.07.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
45 El-Hattab AW, Scaglia F. Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapeutics 2013;10:186-98. [PMID: 23385875 DOI: 10.1007/s13311-013-0177-6] [Cited by in Crossref: 163] [Cited by in F6Publishing: 142] [Article Influence: 18.1] [Reference Citation Analysis]
46 Bakker JA, Schlesser P, Smeets HJ, Francois B, Bierau J. Biochemical abnormalities in a patient with thymidine phosphorylase deficiency with fatal outcome. J Inherit Metab Dis 2010;33 Suppl 3:S139-43. [PMID: 20151198 DOI: 10.1007/s10545-010-9049-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
47 Kipper K, Hecht M, Antunes NJ, Fairbanks LD, Levene M, Kalkan Uçar S, Schaefer A, Blakely EL, Bax BE. Quantification of Plasma and Urine Thymidine and 2'-Deoxyuridine by LC-MS/MS for the Pharmacodynamic Evaluation of Erythrocyte Encapsulated Thymidine Phosphorylase in Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy. J Clin Med 2020;9:E788. [PMID: 32183169 DOI: 10.3390/jcm9030788] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Mathews CK, Song S. Maintaining precursor pools for mitochondrial DNA replication. FASEB J 2007;21:2294-303. [PMID: 17403938 DOI: 10.1096/fj.06-7977rev] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
49 Cabrera-pérez R, Torres-torronteras J, Vila-julià F, Ortega FJ, Cámara Y, Barquinero J, Martí R. Prospective therapeutic approaches in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Expert Opinion on Orphan Drugs 2015;3:1167-82. [DOI: 10.1517/21678707.2015.1090307] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
50 Wenz T, Williams SL, Bacman SR, Moraes CT. Emerging therapeutic approaches to mitochondrial diseases. Dev Disabil Res Rev 2010;16:219-29. [PMID: 20818736 DOI: 10.1002/ddrr.109] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
51 Duran J, Martinez A, Adler E. Cardiovascular Manifestations of Mitochondrial Disease. Biology (Basel) 2019;8:E34. [PMID: 31083569 DOI: 10.3390/biology8020034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
52 Peedikayil MC, Kagevi EI, Abufarhaneh E, Alsayed MD, Alzahrani HA. Mitochondrial Neurogastrointestinal Encephalomyopathy Treated with Stem Cell Transplantation: A Case Report and Review of Literature. Hematol Oncol Stem Cell Ther 2015;8:85-90. [PMID: 25585305 DOI: 10.1016/j.hemonc.2014.12.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
53 Hirano M, Carelli V, De Giorgio R, Pironi L, Accarino A, Cenacchi G, D'Alessandro R, Filosto M, Martí R, Nonino F, Pinna AD, Baldin E, Bax BE, Bolletta A, Bolletta R, Boschetti E, Cescon M, D'Angelo R, Dotti MT, Giordano C, Gramegna LL, Levene M, Lodi R, Mandel H, Morelli MC, Musumeci O, Pugliese A, Scarpelli M, Siniscalchi A, Spinazzola A, Tal G, Torres-Torronteras J, Vignatelli L, Zaidman I, Zoller H, Rinaldi R, Zeviani M. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Position paper on diagnosis, prognosis, and treatment by the MNGIE International Network. J Inherit Metab Dis 2021;44:376-87. [PMID: 32898308 DOI: 10.1002/jimd.12300] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
54 Dreznik Y, Gutman M, Weiss B, Nevler A. Mitochondrial neuro-gastrointestinal encephalomyopathy presenting with recurrent bowel perforations and intra-abdominal abscesses. J Gastrointest Surg 2014;18:2054-6. [PMID: 25022257 DOI: 10.1007/s11605-014-2589-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
55 Cabrera-Pérez R, Vila-Julià F, Hirano M, Mingozzi F, Torres-Torronteras J, Martí R. Alpha-1-Antitrypsin Promoter Improves the Efficacy of an Adeno-Associated Virus Vector for the Treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy. Hum Gene Ther 2019;30:985-98. [PMID: 30900470 DOI: 10.1089/hum.2018.217] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
56 Madhok J, Leong J, Cohn J. Anesthetic Considerations for Liver Transplantation in a Patient with Mitochondrial Neurogastrointestinal Encephalopathy Syndrome. Cureus 2019;11:e5038. [PMID: 31501730 DOI: 10.7759/cureus.5038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
57 Spinazzola A. Mitochondrial DNA mutations and depletion in pediatric medicine. Seminars in Fetal and Neonatal Medicine 2011;16:190-6. [DOI: 10.1016/j.siny.2011.04.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
58 Kripps K, Nakayuenyongsuk W, Shayota BJ, Berquist W, Gomez-Ospina N, Esquivel CO, Concepcion W, Sampson JB, Cristin DJ, Jackson WE, Gilliland S, Pomfret EA, Kueht ML, Pettit RW, Sherif YA, Emrick LT, Elsea SH, Himes R, Hirano M, Van Hove JLK, Scaglia F, Enns GM, Larson AA. Successful liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Mol Genet Metab 2020;130:58-64. [PMID: 32173240 DOI: 10.1016/j.ymgme.2020.03.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
59 Hirano M, Martí R, Casali C, Tadesse S, Uldrick T, Fine B, Escolar DM, Valentino ML, Nishino I, Hesdorffer C, Schwartz J, Hawks RG, Martone DL, Cairo MS, DiMauro S, Stanzani M, Garvin JH Jr, Savage DG. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 2006;67:1458-60. [PMID: 16971696 DOI: 10.1212/01.wnl.0000240853.97716.24] [Cited by in Crossref: 123] [Cited by in F6Publishing: 109] [Article Influence: 7.7] [Reference Citation Analysis]
60 Hussein E. Non-myeloablative bone marrow transplant and platelet infusion can transiently improve the clinical outcome of mitochondrial neurogastrointestinal encephalopathy: a case report. Transfus Apher Sci 2013;49:208-11. [PMID: 23410918 DOI: 10.1016/j.transci.2013.01.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
61 Suomalainen A. Therapy for mitochondrial disorders: little proof, high research activity, some promise. Semin Fetal Neonatal Med 2011;16:236-40. [PMID: 21676668 DOI: 10.1016/j.siny.2011.05.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
62 Hassani A, Horvath R, Chinnery PF. Mitochondrial myopathies: developments in treatment. Current Opinion in Neurology 2010;23:459-65. [DOI: 10.1097/wco.0b013e32833d1096] [Cited by in Crossref: 34] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
63 Torres-Torronteras J, Viscomi C, Cabrera-Pérez R, Cámara Y, Di Meo I, Barquinero J, Auricchio A, Pizzorno G, Hirano M, Zeviani M, Martí R. Gene therapy using a liver-targeted AAV vector restores nucleoside and nucleotide homeostasis in a murine model of MNGIE. Mol Ther 2014;22:901-7. [PMID: 24448160 DOI: 10.1038/mt.2014.6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
64 Nogueira C, Almeida LS, Nesti C, Pezzini I, Videira A, Vilarinho L, Santorelli FM. Syndromes associated with mitochondrial DNA depletion. Ital J Pediatr 2014;40:34. [PMID: 24708634 DOI: 10.1186/1824-7288-40-34] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
65 Schon EA, DiMauro S, Hirano M, Gilkerson RW. Therapeutic prospects for mitochondrial disease. Trends Mol Med 2010;16:268-76. [PMID: 20556877 DOI: 10.1016/j.molmed.2010.04.007] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 6.3] [Reference Citation Analysis]
66 Leuzzi V, Rossi L, Gabucci C, Nardecchia F, Magnani M. Erythrocyte-mediated delivery of recombinant enzymes. J Inherit Metab Dis 2016;39:519-30. [PMID: 27026098 DOI: 10.1007/s10545-016-9926-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
67 Halter J, Schüpbach W, Casali C, Elhasid R, Fay K, Hammans S, Illa I, Kappeler L, Krähenbühl S, Lehmann T, Mandel H, Marti R, Mattle H, Orchard K, Savage D, Sue CM, Valcarcel D, Gratwohl A, Hirano M. Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach. Bone Marrow Transplant 2011;46:330-7. [PMID: 20436523 DOI: 10.1038/bmt.2010.100] [Cited by in Crossref: 82] [Cited by in F6Publishing: 73] [Article Influence: 6.8] [Reference Citation Analysis]